Reddel H.K. Bacharier L.B. Bateman E.D. et al.

Global initiative for asthma strategy 2021: executive summary and rationale for key changes.

Am J Respir Crit Care Med. 205: 17-35Bossé Y. Riesenfeld E.P. Paré P.D. et al.

It's not all smooth muscle: non-smooth-muscle elements in control of resistance to airflow.

Annu Rev Physiol. 72: 437-462Kaminsky D.A. Chapman D.G.

Asthma and Lung Mechanics.

Compr Physiol. 10: 975-1007

Pulmonary physiology.

in: Barnes P. Drazen J. Rennard S. Asthma and COPD. 2nd edition. Elsevier Academic Press, Boston, MABennett G.H. Carpenter L. Hao W. et al.

Risk factors and clinical outcomes associated with fixed airflow obstruction in older adults with asthma.

Ann Allergy Asthma Immunol. 120: 164-168.e161

Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma.

Eur Respir J. 14: 892-896Pellegrino R. Viegi G. Brusasco V. et al.

Interpretative strategies for lung function tests.

Eur Respir J. 26: 948-968Pellegrino R. Brusasco V.

On the causes of lung hyperinflation during bronchoconstriction.

Eur Respir J. 10: 468-475

Gas exchange in disease: asthma, chronic obstructive pulmonary disease, cystic fibrosis, and interstitial lung disease.

Compr Physiol. 1: 663-697Saydain G. Beck K.C. Decker P.A. et al.

Clinical significance of elevated diffusing capacity.

Chest. 125: 446-452Collard P. Njinou B. Nejadnik B. et al.

Single breath diffusing capacity for carbon monoxide in stable asthma.

Chest. 105: 1426-1429Brown R.H. Pearse D.B. Pyrgos G. et al.

The structural basis of airways hyperresponsiveness in asthma.

J Appl Physiol (1985). 101: 30-39

Lessons from structure-function studies in asthma: myths and truths about what we teach.

J Appl Physiol (1985). 101: 7-9Paré P.D. Lawson L.M. Brooks L.A.

Patterns of response to inhaled bronchodilators in asthmatics.

Am Rev Respir Dis. 127: 680-685

Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come.

Clin Exp Allergy. 45: 706-719Gibbons W.J. Sharma A. Lougheed D. et al.

Detection of excessive bronchoconstriction in asthma.

Am J Respir Crit Care Med. 153: 582-589Gelb A.F. Licuanan J. Shinar C.M. et al.

Unsuspected loss of lung elastic recoil in chronic persistent asthma.

Chest. 121: 715-721Tonga K.O. Chapman D.G. Farah C.S. et al.

Reduced lung elastic recoil and fixed airflow obstruction in asthma.

Respirology. 25: 613-619Mansell A. Dubrawsky C. Levison H. et al.

Lung mechanics in antigen-induced asthma.

J Appl Physiol. 37: 297-301McCarthy D.S. Sigurdson M.

Lung elastic recoil and reduced airflow in clinically stable asthma.

Thorax. 35: 298-302Woolcock A.J. Vincent N.J. Macklem P.T.

Frequency dependence of compliance as a test for obstruction in the small airways.

J Clin Invest. 48: 1097-1106Kaminska M. Foley S. Maghni K. et al.

Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction.

J Allergy Clin Immunol. 124: 45-51.e41-44

What Is a significant bronchodilator response?.

Ann Am Thorac Soc. 16: 1495-1497Busse W.W. Holgate S.T. Wenzel S.W. et al.

Biomarker profiles in asthma with high vs low airway reversibility and poor disease control.

Chest. 148: 1489-1496Heffler E. Crimi C. Campisi R. et al.

Bronchodilator response as a marker of poor asthma control.

Respir Med. 112: 45-50Kuo C.R. Chan R. Lipworth B.

Impulse oscillometry bronchodilator response and asthma control.

J Allergy Clin Immunol Pract. 8: 3610-3612Nair P. Martin J.G. Cockcroft D.C. et al.

Airway hyperresponsiveness in asthma: measurement and clinical relevance.

J Allergy Clin Immunol Pract. 5: 649-659.e642Brannan J.D. Lougheed M.D.

Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment.

Front Physiol. 3: 460Cartier A. Thomson N.C. Frith P.A. et al.

Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber.

J Allergy Clin Immunol. 70: 170-177Sumino K. Sugar E.A. Irvin C.G. et al.

Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications.

J Allergy Clin Immunol. 130: 69-75.e66Sumino K. Sugar E.A. Irvin C.G. et al.

Variability of methacholine bronchoprovocation and the effect of inhaled corticosteroids in mild asthma.

Ann Allergy Asthma Immunol. 112: 354-360.e351Tepper R.S. Wise R.S. Covar R. et al.

Asthma outcomes: pulmonary physiology.

J Allergy Clin Immunol. 129: S65-S87Chapman D.G. Berend N. Horlyck K.R. et al.

Does increased baseline ventilation heterogeneity following chest wall strapping predispose to airway hyperresponsiveness?.

J Appl Physiol (1985). 113: 25-30Downie S.R. Salome C.M. Verbanck S. et al.

Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation.

Thorax. 62: 684-689Hardaker K.M. Downie S.R. Kermode J.A. et al.

Ventilation heterogeneity is associated with airway responsiveness in asthma but not COPD.

Respir Physiol Neurobiol. 189: 106-111Lui J.K. Parameswaran H. Albert M.S. et al.

Linking Ventilation Heterogeneity Quantified via Hyperpolarized 3He MRI to Dynamic Lung Mechanics and Airway Hyperresponsiveness.

PLoS One. 10: e0142738Young H.M. Guo F. Eddy R.L. et al.

Oscillometry and pulmonary MRI measurements of ventilation heterogeneity in obstructive lung disease: relationship to quality of life and disease control.

J Appl Physiol (1985). 125: 73-85

Peak flow monitoring in clinical practice and clinical asthma trials.

Curr Opin Pulm Med. 12: 75-81Kaminsky D.A. Wang L.L. Bates J.H. et al.

Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma.

Am J Respir Crit Care Med. 195: 993-999Burgel P.R. Paillasseur J.L. Janssens W. et al.

A simple algorithm for the identification of clinical COPD phenotypes.

Eur Respir J. 50: 1701034Han M.K. Agusti A. Calverley P.M. et al.

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Am J Respir Crit Care Med. 182: 598-604 () ()Roberts S.D. Farber M.O. Knox K.S. et al.

FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age.

Chest. 130: 200-206Coton S. Vollmer W.M. Bateman E. et al.

Severity of Airflow Obstruction in Chronic Obstructive Pulmonary Disease (COPD): Proposal for a New Classification.

Copd. 14: 469-475Deesomchok A. Webb K.A. Forkert L. et al.

Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.

Copd. 7: 428-437

Classifying the Severity of COPD: Are We There Yet? Editorial for "Coton, S. et al. Severity of Airflow Obstruction in Chronic Obstructive Pulmonary Disease (COPD): Proposal for a New Classification".

Copd. 14: 463-464Leaver D.G. Tatterfield A.E. Pride N.B.

Contributions of loss of lung recoil and of enhanced airways collapsibility to the airflow obstruction of chronic bronchitis and emphysema.

J Clin Invest. 52: 2117-2128Tiddens H.A. Bogaard J.M. de Jongste J.C. et al.

Physiological and morphological determinants of maximal expiratory flow in chronic obstructive lung disease.

Eur Respir J. 9: 1785-1794Hogg J.C. Paré P.D. Hackett T.L.

The Contribution of Small Airway Obstruction to the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Physiol Rev. 97: 529-552Pride N.B. Ingram Jr., R.H. Lim T.K.

Interaction between parenchyma and airways in chronic obstructive pulmonary disease and in asthma.

Am Rev Respir Dis. 143: 1446-1449Postma D.S. Kerstjens H.A.

Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease.

Am J Respir Crit Care Med. 158: S187-S192Rijcken B. Schouten J.P. Mensinga T.T. et al.

Factors associated with bronchial responsiveness to histamine in a population sample of adults.

Am Rev Respir Dis. 147: 1447-1453Tashkin D.P. Celli B. Decramer M. et al.

Bronchodilator responsiveness in patients with COPD.

Eur Respir J. 31: 742-750Albert P. Agusti A. Edwards L. et al.

Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease.

Thorax. 67: 701-708Calverley P.M. Burge P.S. Spencer S. et al.

Bronchodilator reversibility testing in chronic obstructive pulmonary disease.

Thorax. 58: 659-664Calzetta L. Rogliani P. Ora J. et al.

LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment.

Eur Respir Rev. 26Hansen J.E. Dilektasli A.G. Porszasz J. et al.

A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.

Ann Am Thorac Soc. 16: 1504-1517Fortis S. Comellas A. Make B.J. et al.

Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.

Ann Am Thorac Soc. 16: 826-835Barjaktarevic I.Z. Buhr R.G. Wang X. et al.

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.

Int J Chron Obstruct Pulmon Dis. 14: 2927-2938Tashkin D.P. Altose M.D. Connett J.E. et al.

Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.

Am J Respir Crit Care Med. 153: 1802-1811van den Berge M. Vonk J.M. Gosman M. et al.

Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD.

Eur Respir J. 40: 1098-1105Scichilone N. Battaglia S. La Sala A. et al.

Clinical implications of airway hyperresponsiveness in COPD.

Int J Chron Obstruct Pulmon Dis. 1: 49-60

Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease.

N Engl J Med. 381: 1248-1256Buist A.S. Vollmer W.M. Johnson L.R. et al.

Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation?.

Am Rev Respir Dis. 137: 293-301Coe C.I. Watson A. Joyce H. et al.

Effects of smoking on changes in respiratory resistance with increasing age.

Clin Sci (Lond). 76: 487-494Cosio M. Ghezzo H. Hogg J.C. et al.

The relations between structural changes in small airways and pulmonary-function tests.

N Engl J Med. 298: 1277-1281Kaminsky D.A. Irvin C.G. Gurka D.A. et al.

Peripheral airways responsiveness to cool, dry air in normal and asthmatic individuals.

Am J Respir Crit Care Med. 152: 1784-1790Yanai M. Sekizawa K. Ohrui T. et al.

Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure.

J Appl Physiol (1985). 72: 1016-1023Woodruff P.G. Barr R.G. Bleecker E. et al.

Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.

N Engl J Med. 374: 1811-1821Day K. Ostridge K. Conway J. et al.

Interrelationships Among Small Airways Dysfunction, Neutrophilic Inflammation, and Exacerbation Frequency in COPD.

Chest. 159: 1391-1399Donaldson G.C. Seemungal T.A. Hurst J.R. et al.

Detrended fluctuation analysis of peak expiratory flow and exacerbation frequency in COPD.

Eur Respir J. 40: 1123-1129Roman-Rodriguez M. Kaplan A.

GOLD 2021 Strategy Report: Implications for Asthma-COPD Overlap.

Int J Chron Obstruct Pulmon Dis. 16: 1709-1715Rodrigues A. de Oliveira J.M. Furlanetto K.C. et al.

Are the Effects of High-Intensity Exercise Training Different in Patients with COPD Versus COPD+Asthma Overlap?.

Lung. 198: 135-141Alshabanat A. Zafari Z. Albanyan O. et al.

Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis.

PLoS One. 10: e0136065

Asthma-COPD Overlap: What Are the Important Questions?.

Chest. 161: 330-344Mart M.F. Peebles Jr., R.S.

Asthma-chronic obstructive pulmonary disease overlap syndrome.

Curr Opin Immunol. 66: 161-166Mekov E. Nuñez A. Sin D.D. et al.

Update on asthma-COPD Overlap (ACO): a narrative review.

Int J Chron Obstruct Pulmon Dis. 16: 1783-1799Milne S. Mannino D. Sin D.D.

Asthma-COPD overlap and chronic airflow obstruction: definitions, management, and unanswered questions.

J Allergy Clin Immunol Pract. 8: 483-495Romem A. Rokach A. Bohadana A. et al.

Identification of asthma-COPD overlap, ASTHMA, AND CHRonic obstructive pulmonary disease phenotypes in patients with airway obstruction: influence on treatment approach.

Respiration. 99: 35-42Sharma S. Khurana S. Federman A.D. et al.

Asthma-chronic obstructive pulmonary disease overlap.

Immunol Allergy Clin North Am. 40: 565-573

Asthma-COPD overlap: review of diagnosis and management.

Curr Opin Pulm Med. 26: 155-161

Physiologic similarities and differences between COPD and asthma.

Chest. 126 (): 117S-124SBacker V. Klein D.K. Bodtger U. et al.

Clinical characteristics of the BREATHE cohort - a real-life study on patients with asthma and COPD.

Eur Clin Respir J. 7: 1736934Gibson P.G. McDonald V.M.

Asthma-COPD overlap 2015: now we are six.

Thorax. 70: 683-691

Early intervention of therapy in asthma.

Curr Opin Pulm Med. 11: 51-55Stern D.A. Morgan W.J. Wright A.L. et al.

Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.

Lancet. 370: 758-764Gelb A.F. Yamamoto A. Verbeken E.K. et al.

Unraveling the Pathophysiology of the Asthma-COPD Overlap Syndrome: Unsuspected Mild Centrilobular Emphysema Is Responsible for Loss of Lung Elastic Recoil in Never Smokers With Asthma With Persistent Expiratory Airflow Limitation.

Chest. 148: 313-320Tai A. Tran H. Roberts M. et al.

The association between childhood asthma and adult chronic obstructive pulmonary disease.

Thorax. 69: 805-810James A.L. Palmer L.J. Kicic E. et al.

Decline in lung function in the Busselton Health Study: the effects of asthma and cigarette smoking.

Am J Respir Crit Care Med. 171: 109-114

Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological study.

Postepy Dermatol Alergol. 31: 372-379Pleasants R.A. Ohar J.A. Croft J.B. et al.

Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment.

Copd. 11: 256-266Park H.Y. Lee S.Y. Kang D. et al.

Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.

Respir Res. 19: 36Lange P. Çolak Y. Ingebrigtsen T.S. et al.

Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.

Lancet Respir Med. 4: 454-462

Aging of the respiratory system: impact on pulmonary function tests and adaptation to exertion.

Clin Chest Med. 26 (): 469-484de Marco R. Pesce G. Marcon A. et al.

The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population.

PLoS One. 8: e62985

Is Chronic Obstructive Pulmonary Disease an Accelerated Aging Disease?.

Ann Am Thorac Soc. 13: S429-S437Silva G.E. Sherrill D.L. Guerra S. et al.

Asthma as a risk factor for COPD in a longitudinal study.

Chest. 126: 59-65Hanania N.A. King M.J. Braman S.S. et al.

Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop.

J Allergy Clin Immunol. 128: S4-S24Sin D.D. Miravitlles M. Mannino D.M. et al.

What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.

Eur Respir J. 48: 664-673Tommola M. Ilmarinen P. Tuomisto L.E. et al.

Differences between asthma-COPD overlap syndrome and adult-onset asthma.

Eur Respir J. 49: 1602383Barrecheguren M. Pinto L. Mostafavi-Pour-Manshadi S.M. et al.

Identification and definition of asthma-COPD overlap: The CanCOLD study.

Respirology. 25: 836-849Krishnan J.A. Nibber A. Chisholm A. et al.

Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices.

Ann Am Thorac Soc. 16: 1143-1150Tkacova R. Dai D.L.Y. Vonk J.M. et al.

Airway hyperresponsiveness in chronic obstructive pulmonary disease: a marker of asthma-chronic obstructive pulmonary disease overlap syndrome?.

J Allergy Clin Immunol. 138: 1571-1579.e1510Lee H.Y. Kang J.Y. Yoon H.K. et al.

Clinical characteristics of asthma combined with COPD feature.

Yonsei Med J. 55: 980-986de Marco R. Marcon A. Rossi A. et al.

Asthma, COPD and overlap syndrome: a longitudinal study in young European adults.

Eur Respir J. 46: 671-679Kitaguchi Y. Yasuo M. Hanaoka M.

Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation.

Int J Chron Obstruct Pulmon Dis. 11: 991-997Suzuki T. Tada Y. Kawata N. et al.

Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome.

Int J Chron Obstruct Pulmon Dis. 10: 947-954Cosio B.G. Soriano J.B. López-Campos J.L. et al.

Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort.

Chest. 149: 45-52Kraemer R. Smith H.J. Gardin F. et al.

Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters.

Int J Chron Obstruct Pulmon Dis. 16: 2487-2500Paredi P. Goldman M. Alamen A. et al.

Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease.

Thorax. 65: 263-267Shirai T. Hirai K. Gon Y. et al.

Forced oscillation technique may identify asthma-COPD overlap.

Allergol Int. 68: 385-387Lu D. Chen L. Fan C. et al.

The value of impulse oscillometric parameters and quantitative hrct parameters in differentiating asthma-COPD overlap from COPD.

Int J Chron Obstruct Pulmon Dis. 16: 2883-2894Tanaka Y. Hirai K. Nakayasu H. et al.

Annual changes in forced oscillation technique parameters correlate with FEV1 decline in patients with asthma, COPD, and asthma-COPD overlap.

Allergol Int. 69: 626-627Fu J.J. Gibson P.G. Simpson J.L. et al.

Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome.

Respiration. 87: 63-74Hardin M. Silverman E.K. Barr R.G. et al.

The clinical features of the overlap between COPD and asthma.

Respir Res. 12: 127Miravitlles M. Soriano J.B. Ancochea J. et al.

Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status.

Respir Med. 107: 1053-1060